Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Decoding GuaB: Machine Learning-Powered Discovery of Enzyme Inhibitors Against the Superbug Acinetobacter baumannii
by
Ahmad, Sajjad
, Aljasir, Mohammad Abdullah
in
Acinetobacter baumannii
/ Analysis
/ Antibiotics
/ Antimicrobial agents
/ antimicrobial resistance (AMR)
/ Bacteria
/ Bacterial infections
/ Candidates
/ Control
/ Datasets
/ Drug development
/ Drug resistance
/ Drug targeting
/ Enzyme inhibitors
/ Enzymes
/ Fatalities
/ Health aspects
/ Hospitals
/ Integrated approach
/ Ligands
/ Machine learning
/ Microbial enzymes
/ MMGB/PBSA
/ molecular docking
/ Multidrug resistant organisms
/ Oxidoreductases
/ Physiological aspects
/ Proteins
/ R&D
/ RDF
/ Research & development
/ Support vector machines
2025
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Decoding GuaB: Machine Learning-Powered Discovery of Enzyme Inhibitors Against the Superbug Acinetobacter baumannii
by
Ahmad, Sajjad
, Aljasir, Mohammad Abdullah
in
Acinetobacter baumannii
/ Analysis
/ Antibiotics
/ Antimicrobial agents
/ antimicrobial resistance (AMR)
/ Bacteria
/ Bacterial infections
/ Candidates
/ Control
/ Datasets
/ Drug development
/ Drug resistance
/ Drug targeting
/ Enzyme inhibitors
/ Enzymes
/ Fatalities
/ Health aspects
/ Hospitals
/ Integrated approach
/ Ligands
/ Machine learning
/ Microbial enzymes
/ MMGB/PBSA
/ molecular docking
/ Multidrug resistant organisms
/ Oxidoreductases
/ Physiological aspects
/ Proteins
/ R&D
/ RDF
/ Research & development
/ Support vector machines
2025
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Decoding GuaB: Machine Learning-Powered Discovery of Enzyme Inhibitors Against the Superbug Acinetobacter baumannii
by
Ahmad, Sajjad
, Aljasir, Mohammad Abdullah
in
Acinetobacter baumannii
/ Analysis
/ Antibiotics
/ Antimicrobial agents
/ antimicrobial resistance (AMR)
/ Bacteria
/ Bacterial infections
/ Candidates
/ Control
/ Datasets
/ Drug development
/ Drug resistance
/ Drug targeting
/ Enzyme inhibitors
/ Enzymes
/ Fatalities
/ Health aspects
/ Hospitals
/ Integrated approach
/ Ligands
/ Machine learning
/ Microbial enzymes
/ MMGB/PBSA
/ molecular docking
/ Multidrug resistant organisms
/ Oxidoreductases
/ Physiological aspects
/ Proteins
/ R&D
/ RDF
/ Research & development
/ Support vector machines
2025
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Decoding GuaB: Machine Learning-Powered Discovery of Enzyme Inhibitors Against the Superbug Acinetobacter baumannii
Journal Article
Decoding GuaB: Machine Learning-Powered Discovery of Enzyme Inhibitors Against the Superbug Acinetobacter baumannii
2025
Request Book From Autostore
and Choose the Collection Method
Overview
GuaB, which is known as inosine 5'-phosphate dehydrogenase (IMPDH), is an enzymatic target involved in the de novo guanine biosynthetic pathway of the multidrug-resistant (MDR)
. GuaB has emerged as a potential therapeutic target to cope with increasing antibiotic resistance. Here, we used machine learning-based virtual screening as a verification technique to find potential inhibitors possessing different chemical scaffolds, using structure-based drug design as a discovery platform.
Four machine learning models, built based on chemical fingerprint data, were trained, and the best models were used for virtual screening of the ChEMBL library, which covers 153 active molecules. Molecular dynamics (MD) simulations of 200 ns were carried out for all three compounds in order to explain conformational changes, evaluate stability, and provide validation of the docking results. Post-simulation analyses include principal component analysis (PCA), bond analysis, free-energy landscape (FEL), dynamic cross-correlation matrix (DCCM), radial distribution function (RDF), salt-bridge identification, and secondary-structure profiling, etc.
For molecular docking, the screened compounds were used against the GuaB protein to achieve proper docked conformation. Upon visual examination of the best-docked compounds, three leads (lead-1, lead-2, and lead-3) were found to have better interaction with the GuaB protein in comparison to the control. The mean RMSD scores between the three leads and the control were between 2.54 and 2.89 Å. In addition, the three leads as well as the control were characterized for pharmacokinetic features. All three leads met Lipinski's Rule 5 and were thus drug-like. PCA and FEL analyses showed that lead-2 exhibited improved conformational stability, identified as deeper energy minima, whereas RDF and DCCM analyses revealed that lead-2 and lead-3 exhibited strong local structuring and concerted dynamics. In addition, lead-2 displayed a very rich hydrogen-bonding network with a total of 460 frames possessing such interactions, which is the highest among the complexes investigated here. Based on entropy calculations and the maximum entropy method of gamma-gram, lead-1 proved to be the most stable one with the lowest binding free-energy.
This study provides an integrated machine learning-based virtual screening pipeline for the identification of new scaffolds to moderate infections associated with AMR; however, in vitro validation is still required to assess the efficacy of such compounds.
This website uses cookies to ensure you get the best experience on our website.